Over 52 weeks of treatment, risankizumab led to significant improvements in both clinical outcomes and optical coherence tomography (OCT) parameters, highlighting the value of long-term therapy in psoriasis. The findings…
One day, there could be a new test to screen for type 1 diabetes, now that scientists have found markers in the blood of the umbilical cords of children who…
Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new research from the University of…
COVID-19 brought about lasting changes that are still being felt today in the post-pandemic era, with one being the unprecedented side effect known as Long COVID. Long COVID is characterized…
A new study found that a sizable minority of people with migraine with aura still receive prescriptions for estrogen-containing birth control pills and hormone therapy, despite treatment contraindications or cautions…
New Delhi: With an aim to curb misuse and unregulated sale of centrally acting medicines, through a recent Gazette notification, the Ministry of Health and Family Welfare (MoHFW) has proposed…
A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research published in The Journal of Nuclear Medicine.…
The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, marking the first dual-agent eye drop therapy for age-related near-vision decline. Unlike previously approved presbyopia drops that contain…
Researchers have found in a new study that injuries sustained at high elevations are linked to significantly higher odds of developing deep vein thrombosis compared with injuries at low elevations.…
USA: A new randomized clinical trial published in NEJM Evidence suggests that solriamfetol may significantly reduce excessive sleepiness in people working early-morning shifts, a population that has received far less…